XML 68 R50.htm IDEA: XBRL DOCUMENT v3.20.4
CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY (Tables)
12 Months Ended
Dec. 31, 2020
CONDENSED FINANCIAL STATEMENTS OF PARENT COMPANY  
Condensed Balance Sheets

December 31, 

Condensed Balance Sheets

    

2020

2019

ASSETS

 

  

 

  

Cash and cash equivalents

 

$

14,270

 

$

9,301

Investment in subsidiaries

157,377

122,792

Loans, net

2,021

2,091

Other assets

4,075

597

Total assets

$

177,743

$

134,781

LIABILITIES

 

  

 

  

Subordinated notes

$

24,291

$

6,560

Other liabilities(1)

 

(1,510)

 

543

Total liabilities

 

22,781

 

7,103

SHAREHOLDERS’ EQUITY

 

  

 

  

Total shareholders’ equity

 

154,962

 

127,678

Total liabilities and shareholders’ equity

$

177,743

$

134,781

_________________________________________________

(1) As of December 31, 2020, taxes payable was in a receivable position as a result of timing of tax payments.

Condensed Statements of Income

Year Ended December 31, 

Condensed Statements of Income

    

2020

2019

Income

 

  

 

  

Interest income

$

87

$

93

Non-interest income

(1)

Total income

86

93

Expense

 

  

 

  

Interest expense

 

854

 

476

Non-interest expense

355

267

Total expense

 

1,209

 

743

Loss before income tax and equity in undistributed income of subsidiaries

 

(1,123)

 

(650)

Income tax benefit

 

(85)

 

49

Loss before equity in undistributed income of subsidiaries

(1,208)

(601)

Equity in undistributed income to subsidiaries

 

25,742

 

8,610

Net income

$

24,534

$

8,009

Condensed Statements of Cash Flows

    

Year Ended December 31, 

Condensed Statements of Cash Flows

2020

2019

Cash flows from operating activities

 

  

 

  

Net income

$

24,534

$

8,009

Adjustments:

Current & deferred income tax (benefit)/expense

(3,003)

282

Stock-based compensation

2,544

2,291

Undistributed equity in subsidiaries

(25,742)

(8,610)

Change in other assets

 

(32)

 

665

Change in other liabilities

(42)

Net cash (used in) provided by operating activities

 

(1,741)

 

2,637

Cash flows from investing activities

Investment in subsidiaries

(10,453)

(2,152)

Loan and note receivable originations and principal collections

 

70

 

Net cash used in investing activities

 

(10,383)

 

(2,152)

Cash flows from financing activities

 

  

 

  

Proceeds from subordinated notes

18,000

Repurchase of common stock

(377)

(743)

Settlement of restricted stock

(261)

(110)

Recognition of capitalized subordinated notes issuance costs

(269)

Net cash provided by (used in) financing activities

 

17,093

 

(853)

Net change in cash and cash equivalents

 

4,969

 

(368)

Cash and cash equivalents, beginning of year

 

9,301

 

9,669

Cash and cash equivalents, end of year

$

14,270

$

9,301

Supplemental cash flow information:

Interest paid on borrowed funds

$

854

$

476

Segment collapse impact to investment in subsidiary

2,454

Segment collapse impact to deferred income tax (benefit)/expense

640

Segment collapse impact to other assets

(3,202)

Segment collapse impact to other liabilities

$

108

$